Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
about
Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolismThe glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferationLinks between metabolism and cancerHIF-1: upstream and downstream of cancer metabolismTargeting Cancer Metabolism - Revisiting the Warburg EffectsRedox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and TherapyAnticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effectMitochondria in Cancer Energy Metabolism: Culprits or Bystanders?Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?Is cancer a metabolic disease?Restoration of mitochondria function as a target for cancer therapyAutophagy: a targetable linchpin of cancer cell metabolismP53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapyCancer cell metabolism: implications for therapeutic targetsSmall-molecule inhibitors of the Myc oncoproteinHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionThe Caenorhabditis elegans Myc-Mondo/Mad complexes integrate diverse longevity signalsMYC is a metastasis gene for non-small-cell lung cancerChanging perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agentsReprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospectsTumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor ImmunityMetabolic consequences of oncogenic IDH mutationsExtracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgeryAnoikis resistance: an essential prerequisite for tumor metastasisSystems-scale analysis reveals pathways involved in cellular response to methamphetamineClotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysisGlucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cellsDifferent Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma CellsThe oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entryHIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanismMYC on the path to cancerThe Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics.tRNA synthetase counteracts c-Myc to develop functional vasculature.The Warburg effect is genetically determined in inherited pheochromocytomasInduction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model.Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR GammaLong term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancerDicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.Racial disparity in metabolic regulation of cancer.Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
P2860
Q24300524-955ABF75-3930-44BB-B0AE-F0B04D41ED6CQ24336894-1AB6633D-4C95-4E2D-8F6A-07C85A4DDCC6Q24626229-0A497A95-1264-4456-9017-A5CFCD48D11EQ24647482-03F30849-071E-4F61-A2DD-CEFD269CD731Q26738876-57CF41F6-0536-40C7-A74C-AC36B9A300BBQ26740191-7112557A-5398-4B72-B85C-F88A431AC823Q26745461-805C8E8B-6AB5-472B-AC23-D3CFCC000A41Q26766062-0C21CE9E-0C0D-47DE-9EB2-41B8BB2FB155Q26774957-1F73ED7E-7FB3-428E-BA1F-1AA897052CE5Q26852241-254013CA-505A-44F0-8726-BA89D468DF2FQ26864167-77E54E4A-FF2A-47EA-8E06-36A48E01F7D9Q27004020-7A775A13-3514-4CBF-BF85-D9A16BF2266AQ27011547-8A250D1C-B263-4961-9A5D-F12D783E850AQ27013632-62FF1B9F-4990-496B-B840-736C58F1E887Q27025648-3C2BDEB9-B954-4DEC-A401-D12537E713EEQ27025886-C8F7C925-6095-4EE5-A10B-C3D00164752CQ27316318-4D3EF453-A818-428B-BCA6-EB42526460B6Q27347283-C1908146-7DC7-492E-9E44-20E6C71CF34AQ28073524-FC9CFEC4-21C6-42BE-9611-B9A8E3420DA8Q28076454-945721B0-2A2A-4464-AE33-A3FDC01B96B2Q28077647-9434C518-B85B-47F6-8E7F-D08AA2902BE1Q28082949-734C62BF-42C9-42F6-8CAC-BF31A95ADE1DQ28250096-2186A090-BB63-4D6F-845F-FAD293161E77Q28397372-DB116C33-0589-4F86-B608-AEC888B990BBQ28477826-FFF5FAA2-62A7-4EDE-8531-4E444661F919Q28480562-0C09ED6F-B476-49A3-AF9A-1E298FA55724Q28504783-008A8FE4-91CA-4FA7-A7BE-ACBB67C1C7CCQ28547526-C387CD98-E89D-427F-8050-53AF29F9B5C9Q28580062-60EAB392-3335-4B9A-B9F7-437CADA9FDB9Q28583933-67B385C2-ABD2-40D2-8F79-80064B843644Q29619979-A180B825-8A19-40D8-A750-D8BB39983A4BQ30252391-FD2608DF-8BCA-4E7D-A358-6695BE421F1AQ31814854-FF1FE900-E86E-465C-9870-70553B0A9FBFQ33504560-09B8EC43-4BF9-48DE-BAC8-EA80A9FD4488Q33734728-C3E98919-5128-40B2-A6EB-C65B882DC119Q33748280-506A172E-ABC2-49B0-B618-59AA2A0F68F3Q33763348-130E3B1B-63C7-4278-96C5-B4FB6A0D2B8EQ33803278-37103C17-1D58-4BF2-BC92-E68DDF063681Q33906704-C5A982A2-7E43-4739-943F-C1C828A48853Q33917658-2989794E-64A1-4EB9-AB66-68B72D7BAE38
P2860
Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@ast
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@en
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@nl
type
label
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@ast
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@en
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@nl
prefLabel
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@ast
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@en
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@nl
P2093
P2860
P3181
P356
P1476
Hypoxia-inducible factor 1 and ...... yruvate dehydrogenase kinase 1
@en
P2093
Gregg L Semenza
Yen-Chun Liu
P2860
P304
P3181
P356
10.1128/MCB.00440-07
P407
P577
2007-09-04T00:00:00Z